Shares of Zoetis (NYSE:ZTS) Sees Large Inflow of Net Money Flow

The shares of Zoetis (NYSE:ZTS) traded with a loss of -1.2 points or -2.53% in the most recent session. The shares last traded at $46.19. As per the trading info, the shares saw $25.28 million in upticks and lost $17.99 million in downticks, resulting in a net money flow of $7.28 million. The up/down ratio for the day was measured at 1.4. For the week, the shares had posted -3.63%.From the block trade data available, the total upticks were valued at $11.44 million and the total downticks were valued at $3.03 million, thereby putting the up/down ratio at 3.77. The net money flow for the block transaction was $8.41 million.


Currently the company Insiders own 0.05% of Zoetis shares according to the proxy statements. Institutional Investors own 93.74% of Zoetis shares.

Zoetis (NYSE:ZTS) stock ended Monday session in the red zone in a volatile trading. The stock closed down 1.2 points or 2.53% at $46.19 with 2,829,876 shares getting traded. Post opening the session at $47.17, the shares hit an intraday low of $46.15 and an intraday high of $47.32 and the price was in this range throughout the day. The company has a market cap of $22,920 million and the number of outstanding shares have been calculated to be 496,202,370 shares. The 52-week high of Zoetis (NYSE:ZTS) is $55.38 and the 52-week low is $37.73.

Many analysts have stated their opinion on the company shares. Citigroup downgrades its view on Zoetis (NYSE:ZTS) according to the research report released by the firm to its investors. The shares have now been rated Neutral by the stock experts at the ratings house. Earlier, the shares had a rating of Buy. Citigroup raises the price target from $46 per share to $50 per share on Zoetis . The rating by the firm was issued on June 10, 2016.

Zoetis Inc. is engaged in the discovery, development, manufacture and commercialization of animal health medicines and vaccines, with a focus on both livestock and companion animals. The Company markets products across four regions: the United States, Europe/Africa/Middle East, Canada/Latin America and Asia/Pacific; eight species: the livestock species of cattle, swine, poultry, sheep and fish, and the companion animal species of dogs, cats and horses, and five product categories: anti-infectives, vaccines, parasiticides, medicated feed additives and other pharmaceutical products. In addition, its Client Supply Services (CSS) organization provides contract manufacturing services to third parties.

Leave a Reply

Get Pre-Market Alerts!

Get Pre-Market Analysts' Upgrades, Downgrades, Earnings & Initiations with our FREE daily email newsletter.